A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries
Clinical trial NCT06539689 · RECRUITING
Trial details
- NCT number
- NCT06539689
- Sponsor
- FrontAce Scientific Co., Ltd
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-04
- Primary completion
- 2026-12-04
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.